Pfizer announced that it has stopped a Phase 3 clinical trail of Lyrica for patients with HIV neuropathy based on an interim analysis of the results. “The results of this study show the complexities of studying pain, particularly in a difficult-to-treat condition such as neuropathic pain associated with HIV neuropathy for which there are no …
Pfizer announced that a Phase 3 randomized withdrawal design study for Lyrica in patients with inadequately treated painful diabetic peripheral neuropathy did not meet its primary efficacy endpoint. READ MORE Source: Marketwatch
Janssen Pharmaceuticals, Inc. presented results at the 31st Annual Scientific Meeting of the American Pain Society suggesting these extended-release tablets were significantly more effective than placebo in providing pain management among adults with chronic moderate to severe, painful diabetic peripheral neuropathy. “Painful DPN is a common and burdensome complication of diabetes, and controlling pain in …
Phase 3 Data Show NUCYNTA® ER Extended-Release Tablets Provide Pain Relief Management Read More »
Read and listen to the video of Dr. Donald I. Abrams, an oncologist, and Jodie Trafton, PhD, director of the Program Evaluation and Resource Center in the Office of Mental Health Operations, Veterans Affairs Palo Alto Health Care System, having a point/counterpoint discussion on marijuana for medicinal purposes. READ MORE Source: Family Practice News
A new drug developed by Tel Aviv University researchers, BL-7050, is offering new hope to patients with neuropathic pain. In both in-vitro and in-vivo experiments measuring electrical activity of neurons, the compound has been shown to prevent the hyperexcitability of neurons – protecting against neuropathic pain. READ MORE Source: Science Daily
In an article that acknowledges that breast cancer is one diagnosis women do not want to hear, Lexi Nisita, contributing writer, talks about the move to alternative treatments for these patients. Many of them are trying to manage the side effects of the drugs, like neuropathy; others are trying to find a holistic alternative to …
Later this year, NeuroMetrix hopes to launch a new device to treat the effects of diabetic peripheral neuropathy (DPN). They are working with the FDA to get their new product through the regulatory process. They currently have a nerve conduction testing product that is used as a diagnostic tool for DPN. READ MORE Source: NeuroMetrix
Rita Woods, LMT (Licensed Massage Therapist) has published instructional articles in Massage Today on the use of massage to benefit diabetic and chemotherapy-induced peripheral neuropathy. Now, she has written an overview article on how to make treatment decisions for neuropathy. READ MORE Source: Massage Today
According to the results of a small pilot study published in Acupuncture in Medicine, acupuncture may help relieve the severe pain associated with chemotherapy-induced peripheral neuropathy. READ MORE Source: Medscape
Fighting ovarian cancer for over 12 years, Barbara McQuade of Ft. Myers, FL, developed neuropathy in her hands and feet. Neuropathy is common in cancer patients. To give patients some relief, Lee Memorial Health System added an acupuncturist to their staff. Being used to treat not just the neuropathy but the nausea, vomiting and dry …
Using Acupuncture for Side Effects of Chemotherapy Read More »
